Review on requirements of drug allergy or pseudoallergic reactions in pre-clinical evaluation.
- Author:
Jia-yin HAN
;
Yan YI
;
Ai-hua LIANG
;
Yu-shi ZHANG
;
Chun-ying LI
;
Yong ZHAO
;
Lian-mei WANG
;
Yu-ting LU
;
Gui-qin LI
- Publication Type:Journal Article
- MeSH:
Drug Hypersensitivity;
diagnosis;
Humans;
Immune System;
drug effects;
Practice Guidelines as Topic
- From:
China Journal of Chinese Materia Medica
2015;40(14):2685-2689
- CountryChina
- Language:Chinese
-
Abstract:
Drug allergy and pseudoallergic reactions are main adverse drug reactions. Allergy is mainly induced by the immunogenicity of drug, drug metabolic products or drug additive. Pseudoallergic reactions may result from the irritation or activation of inflammatory material release. Pre-clinical evaluation of drug allergy and pseudoallergic reactions is included in immunotoxicity evaluation. Now there is no in vivo or in vitro method that could predict all kinds of allergy or pseudoallergic reactions due to the different mechanisms. In the past few years, FDA, SFDA OECD, ICH and WHO have published several guidelines on per-clinical immunotoxicity evaluation, however, no agreement has been reached on allergy and pseudoallergic reactions evaluation. This article reviews the requirements of allergy and pseudoallergic reactions in pre-clinical evaluation.
